Skip to main content
. 2017 Apr 10;32(Suppl 2):83–808. doi: 10.1007/s11606-017-4028-8
Age of onset <50 (n = 477) Age of onset ≥50 (n = 154) ρ
Age, (SD) 31 (9.6) 62 (9.2) <0.01
UC Duration, mean, (SD) 17 (13) 8 (6) 0.10
Influenza Vax 2014 & 2015, n(%) 144 (30.3) 87 (54.7) <0.01
Pneumococcal Vax, w/in past 5 yrs, n(%) 98 (20.6) 68 (42.8) <0.01
DEXA, n(%) 137 (29) 71 (45) <0.01
Anti-TNF Rx, n(%) 82 (17.2) 19 (12) 0.12
HepB assessment prior to Anti-TNF, n(%) 74 (90.2) 18 (94.7) 0.54
Latent TB assessment prior to Anti-TNF, n(%) 77 (93.9) 18 (94.7) 0.89